Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Transarterial Chemoembolization”

288 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 288 results

Not applicableStudy completedNCT00820157
What this trial is testing

Cytoreductive Surgery and Transarterial Chemoembolization (TACE) Versus TACE for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital 120
Testing effectiveness (Phase 2)Study completedNCT05262959
What this trial is testing

A Single Center Study of Donafenib Combined With PD-1 + TACE in the First-line Treatment of aHCC

Who this might be right for
Donafenib
Shanghai Zhongshan Hospital 30
Large-scale testing (Phase 3)Active Not RecruitingNCT04246177
What this trial is testing

Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)

Who this might be right for
Carcinoma, Hepatocellular
Merck Sharp & Dohme LLC 480
Not applicableStudy completedNCT05332821
What this trial is testing

TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Zhongda Hospital 1,244
Testing effectiveness (Phase 2)Ended earlyNCT01381211
What this trial is testing

Transarterial RAdioembolization Versus ChemoEmbolization for the Treatment of Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
University Hospital, Ghent 72
Large-scale testing (Phase 3)UnknownNCT05263219
What this trial is testing

DEB-TACE+HAIC vs. HAIC for Large HCC

Who this might be right for
Unresectable Hepatocellular Carcinoma
Second Affiliated Hospital of Guangzhou Medical University 230
Early research (Phase 1)UnknownNCT03652467
What this trial is testing

The Safety and Efficacy of Deferoxamine for Treating Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Jinan Military General Hospital 100
Testing effectiveness (Phase 2)Looking for participantsNCT07239245
What this trial is testing

Study to Evaluate the Efficacy and Safety of Neo-Adjuvant TACE and Atezolizumab Plus Bevacizumab Therapy for High-Risk Recurrent Hepatocellular Carcinamo

Who this might be right for
Resectable Hepatocellular Carcinoma With High Risk of Recurrence
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 30
Testing effectiveness (Phase 2)Study completedNCT04834674
What this trial is testing

DEB-TACE Combined With Apatinib and PD-1 for the Treatment of Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic CholangiocarcinomaTransarterial ChemoembolizationApatinib+1 more
Sichuan Cancer Hospital and Research Institute 20
Not applicableStudy completedNCT02032368
What this trial is testing

Decrease in Circulating Tumour Cell Count Reflects the Effectiveness of Postoperative Adjuvant Transarterial Chemoembolization (TACE) in Preventing Hepatocellular Carcinoma Recurrence

Who this might be right for
Circulating Tumor Cell;Hepatocellular Carcinoma
Guangdong Provincial People's Hospital 57
Not applicableStudy completedNCT07449065
What this trial is testing

CECT Features of MVI Predict Response to TACE Plus TKI in Intermediate-stage HCC

Who this might be right for
Hepatocellular Carcinoma (HCC)Transarterial ChemoembolizationMicrovascular Invasion (MVI)+1 more
First Affiliated Hospital, Sun Yat-Sen University 324
Testing effectiveness (Phase 2)Study completedNCT00826384
What this trial is testing

Transarterial Chemoembolization (TACE) Therapy of Hepatocellular Carcinoma (HCC) With Blocking Tumor Blood Temporarily and Enhancing Perfusion

Who this might be right for
Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital 352
Not applicableLooking for participantsNCT07408804
What this trial is testing

Comparison of Response Between Combination of Transarterial Chemoembolization and Lenvatinib Therapy Versus Lenvatinib Monotherapy in Patients With Unresectable Hepatocellular Carcinoma

Who this might be right for
Unresectable Hepatocellular Carcinoma (HCC)
Bangladesh Medical University 40
Testing effectiveness (Phase 2)Ended earlyNCT01009801
What this trial is testing

Transarterial Chemoembolization With Doxorubicin With or Without Everolimus in Treating Patients With Liver Cancer

Who this might be right for
Liver Cancer
Swiss Cancer Institute 27
Not applicableStudy completedNCT01839630
What this trial is testing

Sorafenib Concomitantly Used With TACE (Transarterial Chemoembolization) in uHCC (Unresectable Hepatocellular Carcinoma) Patients in China

Who this might be right for
Carcinoma, Hepatocellular
Bayer 302
Early research (Phase 1)Study completedNCT03259581
What this trial is testing

Safety of Transarterial Chemoembolization (TACE) in the Setting of an Elevated Bilirubin

Who this might be right for
Hepatocellular CarcinomaBilirubinemia
University of Minnesota 5
Large-scale testing (Phase 3)Looking for participantsNCT07293468
What this trial is testing

Comparison of SBRT and SIRT With Combination IO for Locally-advanced, Unresectable HCCs (BIIRTH)

Who this might be right for
Hepatocellular Carcinoma (HCC)
Tuen Mun Hospital 106
Not applicableLooking for participantsNCT05717738
What this trial is testing

Combined TACE, TKI/Anti-VEGF and ICIs as Conversion Therapy for Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Tongji Hospital 300
Not applicableStudy completedNCT06265883
What this trial is testing

Lenvatinib Plus DEB-TACE With/Without FOLFOX-HAIC for Large HCC With PVTT

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 205
Not applicableLooking for participantsNCT07351669
What this trial is testing

Prospective Study on the Performance of Spectral CT for Evaluating Treatment Response After TACE in Hepatocellular Carcinoma

Who this might be right for
HCC - Hepatocellular CarcinomaTACE(Transcatheter Arterial Chemoembolization)CT
Zhongda Hospital 250
Load More Results